Bruker Corp (BRKR) Financial Statements
Industry: Laboratory Analytical Instruments
In fiscal 2025, Bruker reported revenue of $3.44B, up 2.1% from $3.37B the year before. Net income was -$8.6M (a -0.3% net margin), or -$0.15 per diluted share. Gross margin was 45.9% and operating margin was 2.0%. Operating activities generated $134.1M of cash, leaving $43.3M of free cash flow. At fiscal year end, Bruker held $6.24B in total assets against $3.73B in total liabilities, including $298.8M of cash and equivalents.
Open the full interactive Bruker financials → Quarterly statements, key ratios, valuation history and price charts.
Bruker Key Stats
| Share Price | $56.19 |
|---|---|
| Market Cap | $8.56B |
| Revenue YoY Growth | +2.1% |
| 52-Week Range | $32.66 – $64.75 |
| Shares Outstanding | 152.3 million (basic, 2026 Q2) |
Bruker Income Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $1.99B | $2.42B | $2.53B | $2.96B | $3.37B | $3.44B |
| Gross Profit | $939.8M | $1.21B | $1.31B | $1.51B | $1.65B | $1.58B |
| Operating Income | $248.3M | $413.3M | $432.7M | $436.9M | $253.1M | $68.2M |
| Pre-Tax Income | $225.8M | $393.6M | $413.9M | $544.2M | $206.9M | $22.0M |
| Income Tax | $64.4M | $113.0M | $116.4M | $117.7M | $91.4M | $29.3M |
| Net Income | $157.8M | $277.1M | $296.6M | $427.2M | $113.1M | -$8.6M |
| Diluted EPS | $1.02 | $1.81 | $1.99 | $2.90 | $0.76 | -$0.15 |
Bruker Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $860.5M | $977.2M | $823.4M | $838.5M |
| Net Income | -$59.6M | $26.0M | $14.4M | -$52.0M |
| Diluted EPS | -$0.41 | $0.17 | $0.02 | -$0.41 |
Bruker Balance Sheet
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $681.8M | $1.07B | $645.5M | $488.3M | $183.4M | $298.8M |
| Current Assets | $1.93B | $2.47B | $2.11B | $2.16B | $2.05B | $2.21B |
| Total Assets | $3.05B | $3.65B | $3.61B | $4.25B | $5.81B | $6.24B |
| Current Liabilities | $791.9M | $938.5M | $914.3M | $1.20B | $1.28B | $1.28B |
| Total Long-Term Debt | $844.5M | $1.33B | $1.22B | $1.28B | $2.09B | $1.87B |
| Total Liabilities | $2.09B | $2.58B | $2.50B | $2.84B | $3.99B | $3.73B |
| Shareholders' Equity | $961.2M | $1.07B | $1.11B | $1.38B | $1.78B | $2.46B |
Bruker Cash Flow Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash From Operations | $332.2M | $282.4M | $274.4M | $350.1M | $251.3M | $134.1M |
| Cash From Investing | -$192.7M | -$192.4M | -$251.6M | -$326.0M | -$1.76B | -$196.5M |
| Cash From Financing | -$161.6M | $318.7M | -$415.3M | -$193.4M | $1.23B | $135.1M |
| Free Cash Flow | $235.0M | $190.4M | $145.2M | $243.2M | $136.0M | $43.3M |
Figures from Bruker's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Bruker financials page for every line item.
Bruker Company Profile
| Ticker | BRKR |
|---|---|
| Exchange | Nasdaq |
| Industry | Laboratory Analytical Instruments |
| Headquarters | Billerica, Massachusetts |
| Incorporated in | Delaware |
| Fiscal Year End | December 31 |
| SEC Filer Category | Large accelerated filer |
| SEC CIK | 0001109354 |
Frequently Asked Questions
What was Bruker's revenue in fiscal 2025?
Bruker (BRKR) reported revenue of $3.44B for fiscal 2025.
What is Bruker's annual revenue history?
Bruker's annual revenue by fiscal year: 2020: $1.99B; 2021: $2.42B; 2022: $2.53B; 2023: $2.96B; 2024: $3.37B; 2025: $3.44B.
What was Bruker's net income in fiscal 2025?
Bruker reported net income of -$8.6M for fiscal 2025.
What was Bruker's earnings per share (EPS) in fiscal 2025?
Bruker's diluted EPS was -$0.15 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did Bruker generate in fiscal 2025?
Bruker generated $43.3M of free cash flow in fiscal 2025.
What was Bruker's revenue last quarter?
In its most recent reported quarter (2026 Q2), Bruker reported revenue of $838.5M.
How much debt does Bruker have?
Bruker reported $1.87B of long-term debt, including the current portion, at the end of fiscal 2025.
How many shares of Bruker are outstanding?
Bruker reported a weighted average of 152.3 million basic shares outstanding in 2026 Q2.
What is Bruker's market cap?
Based on its latest closing price, Bruker (BRKR) has a market capitalization of about $8.56B.
When does Bruker's fiscal year end?
Bruker's fiscal year end, as registered with the SEC, is December 31.
Where is Bruker headquartered?
Bruker lists its business address in Billerica, Massachusetts in its SEC filings.